Understanding whether long-term overexpression of BRD7 in the liver is beneficial for glucose homeostasis would highlight its potential as a therapeutic target for the treatment of obesity and type 2 diabetes. The gene discussed is BRD7; the disease is obesity due to melanocortin 4 receptor deficiency.